We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
This information is for women aged 71 or over. These women no longer receive breast screening invitations, but can request breast screening every 3 years.
The Commission on Human Medicines (CHM) advises ministers on the safety, efficacy and quality of medicinal products. CHM is an advisory non-departmental public body, sponsored by the Department of Health and Social Care .
Hand luggage restrictions at UK airports - carry-on luggage, checked-in baggage, restricted items and liquids, electronic devices carried from Turkey, Lebanon, Egypt and Saudi Arabia
The British Museum (BM) was the first national public museum in the world. Its permanent collection, over 8 million works, is amongst the largest and most comprehensive in existence and originates from every continent, illustrating and documenting the story of...
The Human Fertilisation and Embryology Authority (HEFA) oversees the use of gametes and embryos in fertility treatment and research. It licenses fertility clinics and centres carrying out in vitro fertilisation (IVF), other assisted conception procedures and human embryo research. HFEA...
Information for patients, healthcare professionals and developers of new medicines
The NHS breast surveillance protocols for women at very high risk of developing breast cancer.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
This document contains a synopsis of causation occurring in cancer of the breast.
Guidance for breast screening services on managing a mammographic episode that cannot be completed.
How to support patients in accessing population screening programmes and obtaining screening results.
Technical guidelines for healthcare professionals screening women at a higher risk of developing breast cancer.
Guidance for breast screening services undertaking mammogram reading for another service.
Submit data on women who are already known to the Sloane Project when they have been diagnosed with a further breast cancer, regional or distant event.
NHS breast screening programme procedures to collect, monitor and report repeat mammographic examinations.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).